LRRC66 Activators

Common LRRC66 Activators include, but are not limited to Retinoic Acid, all trans CAS 302-79-4, Dexamethasone CAS 50-02-2, β-Estradiol CAS 50-28-2, Tamoxifen CAS 10540-29-1 and Rapamycin CAS 53123-88-9.

LRRC66 gene, Leucine Rich Repeat Containing 66, encodes a protein that falls under the leucine-rich repeat (LRR) family. Proteins within this family have roles in various biological processes, from cell adhesion and cellular trafficking to hormone-receptor interactions. These proteins, characterized by sequences known as leucine-rich repeats, are essential for numerous cellular functions, including signal transduction and DNA repair. The LRRC66 protein, given its classification, is believed to be involved in intracellular signaling pathways and maintaining cellular homeostasis. LRRC66 Activators may either directly interact with the protein or modulate the associated signaling pathways, resulting in enhanced LRRC66 functionality.

LRRC66 gene has intricate functional associations across eight distinct categories. These include molecular profiles, diseases, chemicals, and more. A particular point of interest is the tissue expression analysis, which indicates that LRRC66 demonstrates heightened expression in specific tissues, notably the intestine and skeletal muscle. However, certain annotations, especially those based on RNA, turned out to be inconclusive. Although the data provides some insight into the gene, the full spectrum of functions, involved pathways, and potential regulatory mechanisms of LRRC66 are yet to be completely elucidated. This highlights the need for continuous research to unearth the comprehensive role of LRRC66 in cellular and physiological contexts.